AMALGAMATED BANK - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,787
-27.7%
66,518
-4.0%
0.02%
-25.0%
Q2 2023$2,470
+35.6%
69,255
-3.4%
0.02%
+25.0%
Q1 2023$1,821
-39.6%
71,700
-3.6%
0.02%
-40.7%
Q4 2022$3,017
-99.9%
74,388
+1.8%
0.03%
+17.4%
Q3 2022$2,415,000
-3.9%
73,081
+2.4%
0.02%0.0%
Q2 2022$2,512,000
-23.1%
71,357
+0.5%
0.02%
-8.0%
Q1 2022$3,266,000
-66.6%
71,009
-51.9%
0.02%
-30.6%
Q4 2021$9,780,000
+113.2%
147,506
+100.8%
0.04%
-7.7%
Q3 2021$4,587,000
-31.8%
73,469
-9.5%
0.04%
-27.8%
Q2 2021$6,722,000
+555.2%
81,165
+424.8%
0.05%
+42.1%
Q1 2021$1,026,000
-19.4%
15,466
-6.7%
0.04%
-20.8%
Q4 2020$1,273,000
+80.1%
16,585
+1.0%
0.05%
+54.8%
Q3 2020$707,000
-3.5%
16,425
-3.2%
0.03%
-8.8%
Q2 2020$733,000
+39.9%
16,965
-6.9%
0.03%
+161.5%
Q1 2020$524,000
-54.0%
18,218
+1.5%
0.01%
-38.1%
Q4 2019$1,138,000
+132.2%
17,944
+3.1%
0.02%
+110.0%
Q3 2019$490,000
+4.7%
17,404
-1.5%
0.01%
-9.1%
Q2 2019$468,000
+89.5%
17,672
+31.4%
0.01%
+83.3%
Q1 2019$247,000
+55.3%
13,444
+5.0%
0.01%
+20.0%
Q4 2018$159,000
-12.2%
12,804
-3.6%
0.01%
+25.0%
Q2 2018$181,00013,2850.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders